Who is sponsoring NCT02166866?

NCT02166866 is sponsored by Mayo Clinic.

What drugs are being tested in NCT02166866?

Interventions in NCT02166866: Quality of Life Questionairre and Education.

What condition does NCT02166866 study?

NCT02166866 studies Cancer Care Recipient.

Is NCT02166866 still recruiting?

NCT02166866 is currently completed. Last updated 29 June 2018.

Last reviewed 2018-06-29 · How we verify

NCT02166866

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Phase I/II Cancer Caregiver Interventions to Improve Quality of Life and Prevent Burnout

Completed Last updated 29 June 2018

What this trial tests

trial testing Quality of Life Questionairre and Education in Cancer Care Recipient in 26 participants. Completed in 27 June 2018.

Timeline

9 September 2013

Primary endpoint
5 May 2015

27 June 2018

Quick facts

Lead sponsor	Mayo Clinic
Status	Completed
Study type	OBSERVATIONAL
Enrollment	26
Start date	9 September 2013
Primary completion	5 May 2015
Estimated completion	27 June 2018
Sites	1 location across United States

Drugs / interventions tested

Quality of Life Questionairre and Education

Conditions studied

Cancer Care Recipient — all drugs for Cancer Care Recipient →

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Cancer Care Recipient. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study defines cancer caregivers as unpaid individuals who provide physical, practical, and/or emotional care and support to the cancer patient in the home setting. They may participate in this study if care recipients and the caregiver are both adults (18 years or older), with the patient having been diagnosed with cancer.The 8 intervention sessions will target the five domains of Quality Of Life (emotional, physical, social, cognitive, and spiritual well-being), be provided in group settings, and be delivered in two 45-minute sessions each week over a 4-week period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02166866 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 29 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02166866.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing